163 related articles for article (PubMed ID: 37865391)
41. Association of Rare Copy Number Variants With Risk of Depression.
Kendall KM; Rees E; Bracher-Smith M; Legge S; Riglin L; Zammit S; O'Donovan MC; Owen MJ; Jones I; Kirov G; Walters JTR
JAMA Psychiatry; 2019 Aug; 76(8):818-825. PubMed ID: 30994872
[TBL] [Abstract][Full Text] [Related]
42. Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments.
Vainieri I; Martin J; Rommel AS; Asherson P; Banaschewski T; Buitelaar J; Cormand B; Crosbie J; Faraone SV; Franke B; Loo SK; Miranda A; Manor I; Oades RD; Purves KL; Ramos-Quiroga JA; Ribasés M; Roeyers H; Rothenberger A; Schachar R; Sergeant J; Steinhausen HC; Vuijk PJ; Doyle AE; Kuntsi J
Psychol Med; 2022 Oct; 52(14):3150-3158. PubMed ID: 33531098
[TBL] [Abstract][Full Text] [Related]
43. Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders.
Chang S; Yang L; Wang Y; Faraone SV
Transl Psychiatry; 2020 Jun; 10(1):182. PubMed ID: 32518222
[TBL] [Abstract][Full Text] [Related]
44. Comparing Copy Number Variations in a Danish Case Cohort of Individuals With Psychiatric Disorders.
Calle Sánchez X; Helenius D; Bybjerg-Grauholm J; Pedersen C; Hougaard DM; Børglum AD; Nordentoft M; Mors O; Mortensen PB; Geschwind DH; Montalbano S; Raznahan A; Thompson WK; Ingason A; Werge T
JAMA Psychiatry; 2022 Jan; 79(1):59-69. PubMed ID: 34817560
[TBL] [Abstract][Full Text] [Related]
45. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
[TBL] [Abstract][Full Text] [Related]
46. The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology.
Brikell I; Larsson H; Lu Y; Pettersson E; Chen Q; Kuja-Halkola R; Karlsson R; Lahey BB; Lichtenstein P; Martin J
Mol Psychiatry; 2020 Aug; 25(8):1809-1821. PubMed ID: 29934545
[TBL] [Abstract][Full Text] [Related]
47. An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder.
Lima Lde A; Feio-dos-Santos AC; Belangero SI; Gadelha A; Bressan RA; Salum GA; Pan PM; Moriyama TS; Graeff-Martins AS; Tamanaha AC; Alvarenga P; Krieger FV; Fleitlich-Bilyk B; Jackowski AP; Brietzke E; Sato JR; Polanczyk GV; Mari Jde J; Manfro GG; do Rosário MC; Miguel EC; Puga RD; Tahira AC; Souza VN; Chile T; Gouveia GR; Simões SN; Chang X; Pellegrino R; Tian L; Glessner JT; Hashimoto RF; Rohde LA; Sleiman PM; Hakonarson H; Brentani H
Sci Rep; 2016 Mar; 6():22851. PubMed ID: 26947246
[TBL] [Abstract][Full Text] [Related]
48. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
[TBL] [Abstract][Full Text] [Related]
49. From Rare Copy Number Variants to Biological Processes in ADHD.
Harich B; van der Voet M; Klein M; Čížek P; Fenckova M; Schenck A; Franke B
Am J Psychiatry; 2020 Sep; 177(9):855-866. PubMed ID: 32600152
[TBL] [Abstract][Full Text] [Related]
50. Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD.
Stergiakouli E; Martin J; Hamshere ML; Langley K; Evans DM; St Pourcain B; Timpson NJ; Owen MJ; O'Donovan M; Thapar A; Davey Smith G
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):322-7. PubMed ID: 25791149
[TBL] [Abstract][Full Text] [Related]
51. Translating Discoveries in Attention-Deficit/Hyperactivity Disorder Genomics to an Outpatient Child and Adolescent Psychiatric Cohort.
Vuijk PJ; Martin J; Braaten EB; Genovese G; Capawana MR; O'Keefe SM; Lee BA; Lind HS; Smoller JW; Faraone SV; Perlis RH; Doyle AE
J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):964-977. PubMed ID: 31421235
[TBL] [Abstract][Full Text] [Related]
52. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder.
Demontis D; Walters RK; Rajagopal VM; Waldman ID; Grove J; Als TD; Dalsgaard S; Ribasés M; Bybjerg-Grauholm J; Bækvad-Hansen M; Werge T; Nordentoft M; Mors O; Mortensen PB; ; Cormand B; Hougaard DM; Neale BM; Franke B; Faraone SV; Børglum AD
Nat Commun; 2021 Jan; 12(1):576. PubMed ID: 33495439
[TBL] [Abstract][Full Text] [Related]
53. Shared genetic etiology between ADHD, task-related behavioral measures and brain activation during response inhibition in a youth ADHD case-control study.
Saraçaydın G; Ruisch IH; van Rooij D; Sprooten E; Franke B; Buitelaar JK; Dietrich A; Hoekstra PJ
Eur Arch Psychiatry Clin Neurosci; 2024 Feb; 274(1):45-58. PubMed ID: 37378697
[TBL] [Abstract][Full Text] [Related]
54. A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model.
Rudd DS; Axelsen M; Epping EA; Andreasen NC; Wassink TH
Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):619-26. PubMed ID: 25228354
[TBL] [Abstract][Full Text] [Related]
55. Polygenic Risk Score-Derived Subcortical Connectivity Mediates Attention-Deficit/Hyperactivity Disorder Diagnosis.
Hermosillo RJM; Mooney MA; Fezcko E; Earl E; Marr M; Sturgeon D; Perrone A; Dominguez OM; Faraone SV; Wilmot B; Nigg JT; Fair DA
Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Mar; 5(3):330-341. PubMed ID: 32033925
[TBL] [Abstract][Full Text] [Related]
56. Reduced burden of very large and rare CNVs in bipolar affective disorder.
Grozeva D; Kirov G; Conrad DF; Barnes CP; Hurles M; Owen MJ; O'Donovan MC; Craddock N
Bipolar Disord; 2013 Dec; 15(8):893-8. PubMed ID: 24127788
[TBL] [Abstract][Full Text] [Related]
57. Genetics of ADHD: What Should the Clinician Know?
Grimm O; Kranz TM; Reif A
Curr Psychiatry Rep; 2020 Feb; 22(4):18. PubMed ID: 32108282
[TBL] [Abstract][Full Text] [Related]
58. The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease.
Liu J; Zhou Y; Liu S; Song X; Yang XZ; Fan Y; Chen W; Akdemir ZC; Yan Z; Zuo Y; Du R; Liu Z; Yuan B; Zhao S; Liu G; Chen Y; Zhao Y; Lin M; Zhu Q; Niu Y; Liu P; Ikegawa S; Song YQ; Posey JE; Qiu G; ; Zhang F; Wu Z; Lupski JR; Wu N
Hum Genet; 2018 Jul; 137(6-7):553-567. PubMed ID: 30019117
[TBL] [Abstract][Full Text] [Related]
59. Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population.
Martin J; Hamshere ML; Stergiakouli E; O'Donovan MC; Thapar A
Biol Psychiatry; 2014 Oct; 76(8):664-71. PubMed ID: 24673882
[TBL] [Abstract][Full Text] [Related]
60. Language deficits in specific language impairment, attention deficit/hyperactivity disorder, and autism spectrum disorder: An analysis of polygenic risk.
Nudel R; Christiani CAJ; Ohland J; Uddin MJ; Hemager N; Ellersgaard DV; Spang KS; Burton BK; Greve AN; Gantriis DL; Bybjerg-Grauholm J; Jepsen JRM; Thorup AAE; Mors O; Nordentoft M; Werge T
Autism Res; 2020 Mar; 13(3):369-381. PubMed ID: 31577390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
